Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/12/13 → 2/12/19 |
Funding
- Kyowa Hakko Kirin Pharma, Inc. (Prot #0761-010)
Prot #0761-010: Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma
- Pro, Barbara (PD/PI)
- Kuzel, Timothy Michael (Other)
Project: Research project